ArticleOncoimmunology

Ibrutinib as an antitumor immunomodulator in patients with refractory chronic lymphocytic leukemia.

Carolina Cubillos-Zapata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.